Sanofi logo

Sanofi(ENXT) SAN

Market Cap$84.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1999)+322%
5 Year+242%
1 Year+34%
1 Month-9%
$71.82
+1.53%
+1.08Today
Sanofi last closing stock price
MetricPriceDate
Last closeEUR 13.362026-10-14
Sanofi stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.23%EUR 13.662026-10-07
1 month-9.4%EUR 14.742026-09-14
3 month-1.95%EUR 13.622026-07-16
Year to date+13.85%EUR 11.732025-12-31
1 year+34.49%EUR 9.932025-10-14
3 year+266.9%EUR 3.642023-10-13
5 year+242.44%EUR 3.902021-10-15
Since inception+322.3%EUR 16.751999-05-25

Sanofi Financials at a Glance

Market Cap

$84.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€48.92B

Net Income (TTM)

€3.96B

EPS (TTM)

$3.33

P/E Ratio

21.16

Dividend

$4.12

Beta (Volatility)

-0.02 (Low)

Price

$71.82

Volume

3,222,320

Open

$70.30

Previous Close

$71.82

Daily Range

$70.10 - $71.82

52-Week Range

$69.75 - $91.15

Estimated Earnings Date

Oct 30, 2026

SAN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sanofi

Sanofi is a global healthcare enterprise dedicated to the research, development, manufacturing, and commercialization of therapeutic solutions. The company operates in three primary divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare, serving markets across the United States, Europe, and beyond.

Products and Services
  • Pharmaceuticals: Specialized treatments for various conditions, including oncology and diabetes
  • Vaccines: Immunizations for pediatric and adult populations, including influenza and meningitis
  • Consumer Healthcare: Over-the-counter remedies for common ailments and personal care products
Growth Outlook
  • Strong pipeline with numerous products in various development stages
  • Strategic collaborations, including partnerships for Covid-19 vaccine development
  • Focus on expanding market presence in emerging economies
Financial Highlights
  • Q2 2026 revenue of €12.3 billion, reflecting a robust growth trajectory
  • Net income of €343 million in Q2 2026, indicating profitability
  • TTM dividend yield of 11.65%, showcasing strong shareholder returns
Sanofi's diverse product offerings and strategic focus on innovation position the company well for future growth. The recent quarterly performance highlights a solid revenue base and profitability, which may attract potential investors. The company's commitment to research and development, along with its strategic partnerships, enhances its competitive edge in the healthcare sector. With a strong dividend yield, Sanofi presents an appealing option for those interested in the pharmaceutical industry.
AI Generated • Oct 10, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

76,493

CEO

Paul Hudson

Website

www.sanofi.com

Headquarters

Paris, IF 75017, FR

SAN Financials

Key Financial Metrics (TTM)

Gross Margin

72.77%

Operating Margin

20.58%

Net Income Margin

8.09%

Return on Equity

5.52%

Return on Capital

10.47%

Return on Assets

3.07%

Earnings Yield

4.73%

Dividend Yield

5.82%

Payout Ratio

1.24%

Stock Overview

Market Cap

$84.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.19B

Volume

3.22M

Avg. Volume

1.99M

Financials (TTM)

Gross Profit

€35.60B

Operating Income

€10.07B

EBITDA

€13.98B

Operating Cash Flow

€17.27B

Capital Expenditure

-€793.00M

Free Cash Flow

€16.48B

Cash & ST Invst.

€6.35B

Total Debt

€23.58B

Sanofi Performance Analysis

Sanofi annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 42,997,000,00013.9%
20232023-12-31EUR 37,817,000,000-12.0%
20242024-12-31EUR 41,081,000,0008.6%
20252025-12-31EUR 43,626,000,0006.2%
Sanofi sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3022.7%
Q42025-12-31-7.3%
Q12026-03-31-7.9%
Q22026-06-309.4%
Sanofi annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 6.6634.6%
20232023-12-31EUR 4.30-35.5%
20242024-12-31EUR 4.433.0%
20252025-12-31EUR 4.25-4.1%
Sanofi sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-29.4%
Q42025-12-31-129.1%
Q12026-03-31303.0%
Q22026-06-30-78.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€12.30B

+14.6%

Gross Profit

€9.28B

+19.9%

Gross Margin

75.47%

N/A

Market Cap

$84.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.13M

N/A

Employees

74,846

N/A

Net Income

€343.00M

-91.3%

EBITDA

€4.03B

+21.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€6.35B

-58.7%

Total Debt

€23.58B

+5.8%

Accounts Receivable

€9.21B

+12.2%

Inventory

€24.12B

+150.8%

Long Term Debt

€16.32B

+10.9%

Short Term Debt

€7.25B

-4.1%

Return on Assets

3.07%

N/A

Return on Invested Capital

10.37%

N/A

Free Cash Flow

€3.35B

+56.8%

Operating Cash Flow

€4.64B

+30.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GSK.LGSK plc
£18.16+3.59%
PFEPfizer Inc.
$29.23+3.02%
AZN.LAstraZeneca PLC
£123.00+3.40%
MRKMerck & Co., Inc.
$147.35+3.78%

Trending Stocks

Symbol / CompanyPricePrice Chg
BACBank of America
$50.96-5.56%
CRWVCoreWeave
$65.23-16.17%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$41.49+10.86%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$114.09-10.57%

Questions About SAN

What is the current price of Sanofi?

Sanofi is trading at $71.82 per share.

What is the 52-week range for Sanofi?

Over the past 52 weeks, Sanofi has traded between $69.75 and $91.15.

How much debt does Sanofi have?

As of the most recent reporting period, Sanofi reported total debt of €20.33B.

How much cash does Sanofi have on hand?

Sanofi reported €7.39B in cash and cash equivalents in its most recent financial results.

What is Sanofi’s dividend yield?

Sanofi currently has a dividend yield of 5.82%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services